Dwayne C. Jones

Array ( [id] => 1102001 [patent_doc_number] => 06815454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'Percutaneously applicable preparation and suppository containing an antidementia medicament' [patent_app_type] => B2 [patent_app_number] => 10/214745 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3045 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815454.pdf [firstpage_image] =>[orig_patent_app_number] => 10214745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745745 [patent_doc_number] => 20030022928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Novel compositions of eprosartan' [patent_app_type] => new [patent_app_number] => 10/213889 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2989 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022928.pdf [firstpage_image] =>[orig_patent_app_number] => 10213889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818261 [patent_doc_number] => 20030069219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Core modified porphyrins' [patent_app_type] => new [patent_app_number] => 10/208395 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13873 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069219.pdf [firstpage_image] =>[orig_patent_app_number] => 10208395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946648 [patent_doc_number] => 06964982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/206765 [patent_app_country] => US [patent_app_date] => 2002-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 8387 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964982.pdf [firstpage_image] =>[orig_patent_app_number] => 10206765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852142 [patent_doc_number] => 20030144345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Treatment of metabolic diseases with soraphen derivatives' [patent_app_type] => new [patent_app_number] => 10/197078 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6520 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144345.pdf [firstpage_image] =>[orig_patent_app_number] => 10197078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281910 [patent_doc_number] => 06642240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Treating emesis in a mammal' [patent_app_type] => B2 [patent_app_number] => 10/190170 [patent_app_country] => US [patent_app_date] => 2002-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33793 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642240.pdf [firstpage_image] =>[orig_patent_app_number] => 10190170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333792 [patent_doc_number] => 06596755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Oral formulation of methylglyoxal and its imino acid conjugates for human use' [patent_app_type] => B2 [patent_app_number] => 10/187422 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3819 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596755.pdf [firstpage_image] =>[orig_patent_app_number] => 10187422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 655275 [patent_doc_number] => 07109329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'Neurologically active compounds and compounds with multiple activities' [patent_app_type] => utility [patent_app_number] => 10/187821 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19117 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109329.pdf [firstpage_image] =>[orig_patent_app_number] => 10187821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436808 [patent_doc_number] => 20040002500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Methods for treating attention deficit disorder' [patent_app_type] => new [patent_app_number] => 10/183527 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7747 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002500.pdf [firstpage_image] =>[orig_patent_app_number] => 10183527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745717 [patent_doc_number] => 20030022900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Compositions comprising alpha-1C specific compounds' [patent_app_type] => new [patent_app_number] => 10/185991 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11210 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022900.pdf [firstpage_image] =>[orig_patent_app_number] => 10185991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688899 [patent_doc_number] => 20030032624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Nitrogen-based camptothecin derivatives' [patent_app_type] => new [patent_app_number] => 10/172211 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20295 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032624.pdf [firstpage_image] =>[orig_patent_app_number] => 10172211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1173675 [patent_doc_number] => 06750235 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Pramipexole as a treatment for cocaine craving' [patent_app_type] => B1 [patent_app_number] => 10/088628 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2226 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750235.pdf [firstpage_image] =>[orig_patent_app_number] => 10088628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196988 [patent_doc_number] => 06727241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Anti-inflammatory compositions and methods of use' [patent_app_type] => B2 [patent_app_number] => 10/171097 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7359 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727241.pdf [firstpage_image] =>[orig_patent_app_number] => 10171097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005468 [patent_doc_number] => 06906064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Method for treating a patient with neoplasia using Iressa' [patent_app_type] => utility [patent_app_number] => 10/166940 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 27752 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906064.pdf [firstpage_image] =>[orig_patent_app_number] => 10166940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721368 [patent_doc_number] => 20030055058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Combination of a PTPase inhibitor and an ACE inhibitor' [patent_app_type] => new [patent_app_number] => 10/163704 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6830 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055058.pdf [firstpage_image] =>[orig_patent_app_number] => 10163704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329722 [patent_doc_number] => 20020198203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Combination of a PTPase inhibitor and a thiazolidinedione agent' [patent_app_type] => new [patent_app_number] => 10/164233 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198203.pdf [firstpage_image] =>[orig_patent_app_number] => 10164233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653268 [patent_doc_number] => 20030008869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Combination of a PTPase inhibitor and a sulfonylurea agent' [patent_app_type] => new [patent_app_number] => 10/163783 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6535 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008869.pdf [firstpage_image] =>[orig_patent_app_number] => 10163783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736074 [patent_doc_number] => 20030013709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Combination of a PTPase inhibitor and an alpha-glucosidase inhibitor' [patent_app_type] => new [patent_app_number] => 10/164232 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6549 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013709.pdf [firstpage_image] =>[orig_patent_app_number] => 10164232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329710 [patent_doc_number] => 20020198202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Combination of a PTPase inhibitor and an antilipemic agent' [patent_app_type] => new [patent_app_number] => 10/164231 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7465 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198202.pdf [firstpage_image] =>[orig_patent_app_number] => 10164231 [rel_patent_id] =>[rel_patent_doc_number] =>)